Suzuki Y. Hypothesis on the Etiology of Skin Complications in Japanese Patients Using Sodium-Glucose Cotransporter 2 Inhibitors. Clin Med Res. 2017 Mar;9(3):229-230. doi: 10.14740/jocmr2897w. Epub 2017 Jan 25. No abstract available
Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys. Sano M, Takei M, Shiraishi Y, Suzuki Y. J Clin Med Res. 2016 Dec;8(12):844-847. Epub 2016 Oct 26. Review.
Sano M, Meguro S, Kawai T, Suzuki Y. Increased grip strength with sodium-glucose cotransporter 2.
J Diabetes. 2016 Sep;8(5):736-7. doi: 10.1111/1753-0407.12402. Epub 2016 Jun 14. No abstract available.
Meguro S, Kawai T, Matsuhashi T, Sano M, Fukuda K, Itoh H, Suzuki Y. Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 Tachyphylaxis. J Endocrinol. 2014;2014:927317. doi: 10.1155/2014/927317. Epub 2014 Mar 11.
Matsuhashi T, Sano M, Fukuda K, Kohsaka S, Suzuki Y . Sitagliptin counteracts seasonal fluctuation of glycemic control. J Diabetes. 2012 Jun 15;3(6):118-22. doi: 10.4239/wjd.v3.i6.118.
Meguro S, Sano M, Kawai T, Matsuhashi T, Mogi S, Fukuda K, Itoh H, Suzuki Y. A new preventive strategy for hypoglycemia incorporating added food diet in patients with type 2 diabetes who received sitagliptin therapy. Endocr Res. 2012;37(4):175-81. doi: 10.3109/07435800.2012.662664. Epub 2012 May 23
Suzuki Y, Sano M, Hayashida K, Ohsawa I, Ohta S, Fukuda K. Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?. FEBS Lett. 2009 Jul 7;583(13):2157-9
Nakashima Y, Ohsawa I, Konishi F, Hasegawa T, Kumamoto S, Suzuki Y, Ohta S.Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice.
Neurosci Lett. 2009 Oct 30;464(3):193-8.
Fu Y, Ito M, Fujita Y, Ito M, Ichihara M, Masuda A, Suzuki Y, Maesawa S, Kajita Y, Hirayama M, Ohsawa I, Ohta S, Ohno K.Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson’s disease.Neurosci Lett. 2009 Apr 3;453(2):81-5.
Ohsawa I, Nishimaki K, Murakami Y, Suzuki Y, Ishikawa M, Ohta S.Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity.J Neurosci. 2008 Jun 11;28(24):6239-49.
Suzuki Y, Ando F, et al。Association of alcohol dehydrogenase 2*1 allele with liver damage and insulin concentration in the Japanese. J Hum Genet. 2006, 51:31-37
Suzuki Y, Fujisawa M, Ando F, et al.Alcohol dehydrogenase 2 variant is associated with cerebral infarction and lacunae. Neurology (United States), Nov 9 2004, 63(9) p1711-3
Suzuki Y, Taniyama M, Muramatsu T, et al.ALDH2/ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes.
Alcohol Clin Exp Res (United States), Aug 2004, 28(8 Suppl Proceedings) p111S-116S
Wang D, Taniyama M, Suzuki Y, Katagiri T, Ban Y. Association of the mitochondrial DNA 5178A/C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients. Exp Clin Endocrinol Diabetes 109巻:361頁-364頁, 2001年
Murata C, Suzuki Y, Muramatsu T, Taniyama M, Atsumi Y,他3名. Inactive Aldehyde dehydrogenase 2 worsens glycemic control in patients with type 2 diabetes mellitus who drink low to moderate amounts of alcohol. Alcohol Clin Exp Res 24巻: 5S頁-11S頁, 2000年
Momiyama Y, Suzuki Y. Ohsuzu F, Atsumi Y, Matsuoka K, 他１名. Maternally transmitted susceptibility to non-insulin-dependent diabetes mellitus and left ventricular hypertrophy. J Am Coll Cardiol 33巻：1372頁-1378頁, 1999年
Tsukuda K, Suzuki Y, Kameoka K, Osawa N, Goto Y, 他4名. Screening of patients with maternally transmitted diabetes for mitochondrial gene mutations in the tRNA region. Diabetic Medicine 14巻: 1032頁-1037頁, 1997年
Suzuki Y, Iizuka T, Kobayashi T, Nishikawa T; Atsumi Y; 他7名。Diabetes mellitus associated with the 3243 mitochondrial tRNA mutation: insulin secretion and sensitivity. Metabolism 46巻: 1019頁-1023頁, 1997年
Suzuki Y, Goto Y, Taniyama M, Nonaka I, Murakami N,他４名. Muscle histopathology in diabetes mellitus associated with mitochondrial tRNA mutation at position 3243. Journal of Neurological Sciences 145巻: 49頁-53頁, 1997年
Suzuki Y, Taniyama M, Muramatsu T, Atsumi Y, Hosokawa K, 他4名. Diabetes mellitus associated with 3243 mitochondrial tRNA mutation : Clinical features and coenzyme Q10 treatment. Molec Aspects Med 18巻: s181頁-188頁, 1997年
Suzuki Y, Hosokawa K, Atsumi Y, Matsuoka K. Maternal inherited diabetes is predominant in Japanese and has influence on siblings. Diabetes mellitus: New aspects of pathogenesis and treatment. Eds: T. Kaneko, K.B. Huh, M. Shichiri, Y. Oka, Smith Gordon, 53頁-55頁, 1997年
Miyaoka H, Suzuki Y, Taniyama M, Miyaoka Y, Shishikura K,他3名. Mental disorders in diabetic patients with mitochondrial transfer RNA mutation at position 3243. Biol Psychiatry 42巻: 524頁-526頁, 1997年
Suzuki Y, Kadowaki H, Atsumi Y, Hosokawa K, Katagiri H,他６名. A case of diabetic amyotrophy associated with 3243 mitochondrial tRNA mutation and successful therapy with coenzyme Q10. Endocrine Journal 42巻:144頁-145頁,1995年
Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, 他5名. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Eng J Med 330巻: 962頁- 968頁, 1994年
Suzuki Y. Painless blood sampling for self blood glucose measurement: Lancet 339巻: 816頁?817頁, 1992年
(欧文総説)
Suzuki Y. Aldehyde dehydrogenase and diabetes mellitus. Focus on diabetic retinopathy 4巻:28頁-33頁, 1997年(Review)
Suzuki Y, Matsuoka K. Maternal inheritance of diabetes mellitus and diabetic neuropathy. Diabetic neuropathy: new concepts and insights. eds. Hotta N, Greene DA, et al. Elsevier Science B.V. : 209頁-211頁, 1995年
2021年現在、雑誌 Lancetのインパクトファクターは、59.102です。
2021年現在、雑誌 New England Journal of Medicine（NEJM）のインパクトファクターは、74.699です。
2021年現在、雑誌 Neurology のインパクトファクターは、8.609 です。
2021年現在、雑誌 Metabolism のインパクトファクターは、7.196 です。
2021年現在、雑誌 FEBS Letters のインパクトファクターは、3.902 です。
2021年現在、雑誌 Diabetes Medicine のインパクトファクターは、3.342 です。